CircRNA Synthesis Market Report Scope & Overview:
CircRNA synthesis market size was valued at USD 183.58 million in 2024 and is expected to reach USD 592.84 million by 2032, growing at a CAGR of 15.85% over the forecast period of 2025-2032.
The CircRNA synthesis market is growing rapidly due to the rising interest in circular RNAs for gene regulation, biomarker discovery, and therapeutic applications. Recent advances in RNA sequencing technologies and synthetic biology enable the efficient synthesis and functional characterization of circRNAs. Market demand is furthering growth due to growing investments in RNA-based drug development and expansion of research in oncology, neurology, and rare diseases. Both academic and commercial uptake of circRNA technologies are fully expected to drive this market into accelerated growth.
The U.S. CircRNA synthesis market size was valued at USD 62.32 million in 2024 and is expected to reach USD 198.32 million by 2032, growing at a CAGR of 15.63% over the forecast period of 2025-2032.
North America generates the maximum revenue in the CircRNA Synthesis market, led by the U.S, which has an advanced biotechnological sector, excellent infrastructure to perform RNA experiments, and the highest funding for research and development. Numerous well-established academic institutes and cutting-edge biotech companies complement the platform, reinforcing the region's leadership in the development and synthesis of circRNA.
Market Dynamics:
Drivers
-
Advancements in RNA Technologies are Driving the Market Growth
Development of stable and functional RNA towards various RNA technologies has also facilitated the floor of circular RNA (circRNA) synthesis. Compared with traditional linear RNA, the extreme stability and outstanding resistance to exonuclease degradation of circRNAs have made them excellent delivery vehicles for gene therapy, vaccine delivery, and protein replacement strategies. The resulting technological improvements have facilitated increased specificity in circRNAs synthesis and their editing, along with the large-scale production, which are driving the uptake in pharmaceutical and academic settings.
-
Increasing Attention Towards RNA-Based Therapeutics is Propelling the Market Growth
CircRNAs have emerged as the next big target for RNA-based drug discovery for biopharma. Their special feature of acting as protein templates and regulating gene expression has put circRNAs high on the list of targets for drug targeting. circRNAs can overcome the limitation of linear mRNA therapies, despite their potential to provide immunogenicity or short half-life, they can also be engineered to enlarge the payload and expand application scope. This unprecedented increase in the number of research studies and preclinical trials of circRNA-based therapeutics is driving demand for fast-acting and large-scale synthesis platforms, contributing to the growth in the market.
Restraint
-
Absence of Standardized Protocols and Analytical Methods is Restraining the Market from Growing
The lack of standard procedures for the synthesis, purification, enrichment, quantification, and quality assessment of circRNAs represents a critical bottleneck in the field. Compared to linear RNA, circRNA consists of a covalently closed loop structure, which presents challenges for detection and validation with traditional approaches. Public laboratories currently employ various approaches (e.g., RNase R treatment, divergent primers in qPCR, or dedicated RNA-seq pipelines), contributing to non-uniform results and a lack of reproducibility between studies.
The unavailability of such standardization not only limits the potential of academic research but also negatively impacts the scalability and regulatory approval of these novel circRNA-based diagnostics and therapeutics. Lack of defined guidelines leads to obstacles for ensuring quality, consistency, and safety of products, and limits the willingness of pharmaceutical or biotech companies to commit major funds to commercial applications. As a result, this continues to be one of the major constraints in which the market is experiencing a maturity lag and limited uptake.
Segmentation Analysis:
By Product & Service
The reagents & kits segment dominated the CircRNA synthesis market share with a 48.25% in 2024, as these products are essential for achieving consistently accurate, high-throughput, and reproducible synthesis processes, both in a research and clinical setting. They are used in a wide range of molecular biology labs due to their convenience, reproducibility, quality, and compatibility with high-throughput platforms. In addition, a strong interest in academic and commercial research on circRNA functions, therapeutic applications, and biomarker development has generated increased demand for high-quality kits and reagents to support experimental workflows.
The services segment is expected to grow at the fastest rate during the forecast period, owing to the increasing complexity of circRNA-based research and demand for personalized synthesis, sequencing, and bioinformatics analysis. To alleviate operational burden and quicken discovery timelines, many research institutions and biotech companies are now outsourcing these services to specialized providers. Similarly, demand for end-to-end service offerings that involve the synthesis and functional validation of circRNA is likely to witness increased uptake owing to the increasing number of circRNA therapeutics likely to enter downstream stages of product development over the next few years, a factor anticipated to accelerate the growth of this segment.
By Type of Synthesis
The enzymatic synthesis segment accounted for the largest share of the circRNA synthesis market in 2024 and is expected to grow during the forecast period due to high efficiency, scalability & the ability to produce circRNA with minimal contamination. Enzymatic methods, including ligation and permuted intron-exon (PIE) strategies, provide greater precision in circularizing RNA without the use of extreme conditions or hazardous reagents, both of which are key in maintaining RNA integrity. During research and the initial stage of therapy development, high yields of biologically active circRNAs are crucial, and these methods have been broadly utilized.
The chemical synthesis segment is expected to grow at a significant rate over the forecast period due to improvements made in synthetic chemistry, automation, and precision engineering. While the in vivo transfection of circRNA provides limited customization of circRNA sequences with lesions, which is more suitable for basic research, chemical synthesis has more flexibility on the customization of circRNA sequences and the introduction of chemical modifications, which is regarded as a high-throughput technology and a new concept in therapeutics. Recently, circRNA-based therapeutics (i.e., gene therapy and cancer immunotherapy) are burgeoning, highlighting the urgent need for chemically synthesized circRNAs with high stability and reagent-specific functions.
By Application
The therapeutics development segment dominated the circRNA synthesis market in 2024 it is due to the rising interest in circular RNAs as both precision medicine and RNA-based therapeutics tools. Due to their remarkable stability, low immunogenicity, and high translational efficiency, circRNAs are attractive candidates for therapeutic applications, especially in oncology, cardiovascular disease, and neurological disorders. The increased focus on clinical studies and collaborative efforts between these pharmaceutical companies and traditional academic institutions has drawn a list of several circRNA-based therapeutic candidates in the pipeline, along with some new investments in synthesis platforms more closely designed for therapeutic use.
The drug discovery segment is expected to grow at the highest rate over the forecast period as more circRNAs are being utilized in preclinical and target validation steps of drug discovery. They are relatively stable, and circRNAs are being widely investigated as potential biomarkers and molecular tools for understanding regulatory networks and disease. They are characterized by a distinctive circular structure and wide-ranging regulatory roles that support their potential as novel therapeutic target identifiers.
By End Use
In 2024, the pharmaceutical and biotechnology companies segment held the largest share of the circRNA synthesis market due to major investments by pharmaceutical and biotechnology companies in advancements in RNA-based therapeutic platforms. They are well-positioned, both with a strong R&D infrastructure and funding ability to translate circRNA research into the development of clinical therapeutics. In this segment, the growing attention towards RNA-targeted drug discovery, demand for new therapeutic modalities, and collaborations with RNA technology startups have continued to drive circRNA synthesis solutions.
In the forecast period, the academic and research institutes segment is projected to grow at the fastest rate due to the rising interest in the biological functions and regulatory mechanisms of circRNAs, particularly their involvement in the regulation of gene expression, disease development and progression, and cellular signaling, which is likely contributing to the increased output. Academic institutions are quickly implementing circRNA synthesis technologies as government agencies and private foundations increase funding for RNA biology research.
Regional Analysis:
North America dominated the CircRNA synthesis market trend with a 44.6% market share in 2024, owing to the highly developed biotechnology and pharmaceutical industry, and with the presence of a large amount of funding, both government and private sector support. The high presence of market players, academic research institutes, and infrastructure on RNA-based therapeutics around the region delivers aptitude for backing RNA diagnostics development in the region. The increasing adoption of next-generation sequencing and transcriptomics technologies, as well as the increasing number of clinical trials, are further driving the demand for circRNA synthesis in the region.
The CircRNA synthesis market growth in Asia Pacific is due to the increasing biotechnology government initiatives, rising investments in genomic research, and growing collaborations with global pharmaceutical companies. With biotech startups fostered by growing government support and more friendly regulations, nations like China, Japan, and South Korea quickly build up their RNA game. Moreover, the increasing prevalence of chronic diseases and the growing need for personalized medicine are also significantly promoting the fast growth rate of this region.
Europe is expected to emerge as a significant regional circRNA synthesis market analysis due to well-established pharmaceutical and biotechnology infrastructure, with the government providing solid support for genomics studies, and increasing academic and commercial research partnerships. Germany, the UK, and France have well-established clinical research organizations and a strong tax, research, and development base, coupled with access to skilled R&D centres that are leveraging RNA-based drug discovery initiatives.
In addition, increasing investments in personalized medicine and molecular diagnostics are expected to result in an upsurge in the demand for highly advanced RNA synthesis technology within the region. European regulators are also gradually giving the nod to RNA-based drugs, so the climate of innovation is good! This synthetic and institutional, and policy-driven momentum paves the way for Europe to be a significant player in the gene-drives and circRNAs synthesis market globally.
Growth in the circRNA synthesis market in Latin America and the MEA regions is moderate in over the forecast period, due to the awareness about the role and benefits of RNA-Based Technologies, coupled with the expanding academic and clinical research activities although currently trailing in large-scale biotechnology infrastructure, there are gradual market developments fuelled by a better healthcare systems, investments in life sciences and partnerships with global research institutions taking place in these regions. In addition, increasing government initiatives to improve biomedical research and the rising interest in precision medicine are also providing significance for the continued growth of the circRNA synthesis technologies.
Key Players:
CircRNA synthesis market companies are Synbio Technologies, GenScript, Creative Biogene, OriGene Technologies, Thermo Fisher Scientific, Bio-Synthesis Inc., Twist Bioscience, Syntezza Bioscience, VectorBuilder, Vigene Biosciences, Dharmacon (Horizon Discovery), Eurofins Genomics, Bioneer Corporation, Sangon Biotech, TriLink BioTechnologies, Baseclick GmbH, Integrated DNA Technologies (IDT), Macrogen, GeneUniversal, Genewiz, and other players.
Recent Developments:
-
September 18, 2023 – GenScript Biotech Corporation, a global leader in life science research tools and services, today announced the expansion of its in vitro transcription (IVT) mRNA synthesis platform. GenScript has added new tailored services for circular RNA (circRNA) synthesis and lipid nanoparticle (LNP) formulation to help facilitate cutting-edge research and therapy development efforts.
-
August 2024 – Abogen Biosciences has developed a very effective RNA circularization platform called the Cis-Splicing System (Cis-System). The new system enables the creation of circular RNA (circRNA), marking a milestone in RNA-based therapeutic technologies.
CircRNA Synthesis Market
Report Attributes Details Market Size in 2024 USD 183.58 million Market Size by 2032 USD 592.84 million CAGR CAGR of 15.85% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segments • By Product & Service (Reagents & Kits, Instruments, Services)
• By Type of Synthesis (Chemical Synthesis, Enzymatic Synthesis, In vitro Transcription-Based Synthesis)
• By Application (Therapeutics Development, Drug Discovery, Gene Therapy, RNA Vaccine Development, Functional Genomics Studies, Molecular Diagnostics)
• By End Use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories)Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Company Profiles CircRNA synthesis market companies are Synbio Technologies, GenScript, Creative Biogene, OriGene Technologies, Thermo Fisher Scientific, Bio-Synthesis Inc., Twist Bioscience, Syntezza Bioscience, VectorBuilder, Vigene Biosciences, Dharmacon (Horizon Discovery), Eurofins Genomics, Bioneer Corporation, Sangon Biotech, TriLink BioTechnologies, Baseclick GmbH, Integrated DNA Technologies (IDT), Macrogen, GeneUniversal, Genewiz, and other players.
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product & Service
2.3.2 Market Size By Type of Synthesis
2.3.2 Market Size By Application
2.3.2 Market Size By End Use
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 R&D Activity and Patent Trends in circRNA Synthesis
4.1.1 Number of circRNA Patents Filed, by Region (2020–2024)
4.1.2 Key Organizations Leading in circRNA-related Publications
4.1.3 Innovation Clusters and Emerging Research Institutions
4.2 Funding Landscape and Investment Trends
4.2.1 Public and Private Funding for circRNA Synthesis (2020–2024)
4.2.2 Venture Capital and Biotech Startup Activity
4.2.3 Notable M&A and Partnership Deals in the Market
4.3 Academic and Industry Collaborations
4.3.1 University-Biotech Collaborations (2020–2024)
4.3.2 Global Research Consortia Involving circRNA
4.3.3 Government-sponsored Programs in circRNA Synthesis
4.4 circRNA Clinical Trials and Therapeutic Pipeline
4.4.1 Number of Ongoing and Completed Trials (2020–2024)
4.4.2 Therapeutic Areas of Focus (Oncology, Rare Diseases, etc.)
4.4.3 Regulatory Status and Approvals Pipeline
4.5 Manufacturing and Synthesis Capacity Trends
4.5.1 Global circRNA Synthesis Facility Distribution
4.5.2 Scale-up Capacity: Preclinical vs Commercial Production
4.5.3 Technology Platforms for circRNA Synthesis (Enzymatic, Chemical, etc.)
4.6 Global Usage and Adoption Rate
4.6.1 Adoption Rate of circRNA Tools in Academic Labs
4.6.2 Industry Use of circRNA Synthesis Kits and Services
4.6.3 Regional Penetration and Utilization Trends (2020–2024)
5. CircRNA Synthesis Market Segmental Analysis & Forecast, By Product & Service, 2021 – 2032, Value (USD Million)
5.1 Introduction
5.2 Reagents & Kits
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Instruments
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Services
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
6. CircRNA Synthesis Market Segmental Analysis & Forecast,
By Type of Synthesis, 2021 – 2032, Value (USD Million)
6.1 Introduction
6.2 Chemical Synthesis
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Enzymatic Synthesis
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 In vitro Transcription-Based Synthesis
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. CircRNA Synthesis Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Million)
7.1 Introduction
7.2 Therapeutics Development
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Drug Discovery
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Gene Therapy
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 RNA Vaccine Development
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Functional Genomics Studies
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
7.7 Molecular Diagnostics
7.7.1 Key Trends
7.7.2 Market Size & Forecast, 2021 – 2032
8. CircRNA Synthesis Market Segmental Analysis & Forecast, By End Use , 2021 – 2032, Value (USD Million)
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Academic and Research Institutes
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Contract Research Organizations (CROs)
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Diagnostic Laboratories
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. CircRNA Synthesis Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Million)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.2.3 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.2.4 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.2.5 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.2.6 CircRNA Synthesis Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.2.6.1.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.2.6.1.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.2.6.1.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.2.6.2.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.2.6.2.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.2.6.2.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.3 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.4 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.5 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6 CircRNA Synthesis Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.1.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.1.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.1.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.2.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.2.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.2.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.3.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.3.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.3.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.4.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.4.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.4.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.5.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.5.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.5.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.6.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.6.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.6.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.7.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.7.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.7.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.8.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.3.6.8.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.3.6.8.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.3 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.4 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.5 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6 CircRNA Synthesis Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.1.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.1.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.1.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.2.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.2.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.2.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.3.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.3.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.3.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.4.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.4.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.4.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.5.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.5.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.5.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.6.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.6.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.6.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.7.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.4.6.7.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.4.6.7.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.3 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.5.4 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.5.5 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6 CircRNA Synthesis Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.1.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.5.6.1.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.5.6.1.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.2.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.5.6.2.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.5.6.2.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.3.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.5.6.3.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.5.6.3.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.4.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.5.6.4.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.5.6.4.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.5.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.5.6.5.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.5.6.5.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.3 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.4 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.5 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6 CircRNA Synthesis Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.1.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.6.1.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.6.1.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.2.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.6.2.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.6.2.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.3.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.6.3.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.6.3.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.4.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.6.4.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.6.4.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.5.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.6.5.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.6.5.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 CircRNA Synthesis Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.6.2 CircRNA Synthesis Market Size & Forecast, By Application, 2021 – 2032
9.6.6.6.3 CircRNA Synthesis Market Size & Forecast, By Type of Synthesis, 2021 – 2032
9.6.6.6.4 CircRNA Synthesis Market Size & Forecast, By End Use, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Synbio Technologies
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 GenScript
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Creative Biogene
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 OriGene Technologies
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Thermo Fisher Scientific
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Bio-Synthesis Inc.
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Twist Bioscience
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Syntezza Bioscience
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 VectorBuilder
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Vigene Biosciences
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Dharmacon (Horizon Discovery)
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Eurofins Genomics
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Bioneer Corporation
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Sangon Biotech
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 TriLink BioTechnologies
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Baseclick GmbH
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Integrated DNA Technologies (IDT)
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Macrogen
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 GeneUniversal
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Genewiz
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
CircRNA Synthesis Market
Key Segments:
By Product & Service
-
- Reagents & Kits
- Instruments
- Services
By Type of Synthesis
- Chemical Synthesis
- Enzymatic Synthesis
- In vitro Transcription-Based Synthesis
By Application
-
- Therapeutics Development
- Drug Discovery
- Gene Therapy
- RNA Vaccine Development
- Functional Genomics Studies
- Molecular Diagnostics
By End Use
-
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Diagnostic Laboratories
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
